Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ocean Biomediacal, Inc.

0.0061
+0.00011.67%
Volume:604.87K
Turnover:3.41K
Market Cap:1.42M
PE:-0.01
High:0.0063
Open:0.0054
Low:0.0054
Close:0.0060
52wk High:1.16
52wk Low:0.0030
Shares:232.37M
Float Shares:208.41M
Volume Ratio:0.62
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7074
EPS(LYR):-0.3447
ROE:--
ROA:-114.87%
PB:-0.02
PE(LYR):-0.02

Loading ...

Company Profile

Company Name:
Ocean Biomediacal, Inc.
Exchange:
PINK LIMITED
Establishment Date:
2019
Employees:
7
Office Location:
55 Claverick Street,Room 325,Providence,Rhode Island,United States
Zip Code:
02903
Fax:
- -
Introduction:
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP. The company is based in Providence, Rhode Island. Ocean Biomedical, Inc. operates as a subsidiary of Poseidon Bio, LLC.